- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hansa Biopharma AB (24H)
"Hansa Biopharma AB stock price live, this page displays ST HNSA stock exchange data. View the HNSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hansa Biopharma AB real time stock price chart below.
What Is the Hansa Biopharma AB Stock Price Today?
The Hansa Biopharma AB stock price today is 2.2000.
What Is the Stock Symbol for Hansa Biopharma AB?
The stock symbol for Hansa Biopharma AB is ""HNSA.""
What Stock Exchange Does Hansa Biopharma AB Trade On?
Hansa Biopharma AB is listed and trades on the Stockholm stock exchange.
Is Hansa Biopharma AB a Good Stock to Buy?
Determining whether Hansa Biopharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HNSA quote. (ISIN: SE0002148817)"
What Is the Hansa Biopharma AB Stock Price Today?
The Hansa Biopharma AB stock price today is 2.2000.
What Is the Stock Symbol for Hansa Biopharma AB?
The stock symbol for Hansa Biopharma AB is ""HNSA.""
What Stock Exchange Does Hansa Biopharma AB Trade On?
Hansa Biopharma AB is listed and trades on the Stockholm stock exchange.
Is Hansa Biopharma AB a Good Stock to Buy?
Determining whether Hansa Biopharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HNSA quote. (ISIN: SE0002148817)"
2.2000
-0.1140(-4.93%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.2000
2.2000
52 wk Range
1.7320
4.8000
24H Scorecard
Full Analysis
Quickly burning through cash
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.20002.2000
52 wk Range
1.73204.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
24H Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Hansa Biopharma AB Company Profile
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Compare 24H to Peers and Sector
Metrics to compare | 24H | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship24HPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −7.7x | −0.5x | |
PEG Ratio | −0.06 | −0.19 | 0.00 | |
Price/Book | −2.7x | 6.2x | 2.6x | |
Price / LTM Sales | 9.4x | 20.2x | 2.9x | |
Upside (Analyst Target) | - | 103.9% | 56.4% | |
Fair Value Upside | Unlock | 11.1% | 9.3% | Unlock |
Earnings
Latest Release
Mar 21, 2025
EPS / Forecast
-4.08 / --
Revenue / Forecast
32.34M / --
People Also Watch
FAQ
What Is the Hansa Biopharma AB (24H) Stock Price Today?
The Hansa Biopharma AB stock price today is 2.20
What Stock Exchange Does Hansa Biopharma AB Trade On?
Hansa Biopharma AB is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for Hansa Biopharma AB?
The stock symbol for Hansa Biopharma AB is "24H."
What Is the Hansa Biopharma AB Market Cap?
As of today, Hansa Biopharma AB market cap is 155.53M.
What is Hansa Biopharma AB Earnings Per Share?
The Hansa Biopharma AB EPS is -9.39.
From a Technical Analysis Perspective, Is 24H a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.